Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
10/2010
10/05/2010US7807677 1-[N'-[(R)-4-Hydroxy-4-((1S,2R)-2-hydroxy-indan-1-yl]carbamoyl)-5-phenyl-pentyl]-N'-(4-pyridin-4-yl-benzyl)-hydrazinocarbonyl]-2,2-dimethyl-propyl-carbamic acid methyl ester; effective against strains resistant to squinavir, ritonavir, and indinavir; improved bioavailability
09/2010
09/30/2010WO2010110484A1 Onium salt with (trialkoxysilyl)alkyl group
09/30/2010WO2010078449A3 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
09/30/2010US20100249181 HIV Protease Inhibiting Compounds
09/30/2010US20100249135 Sulfonamides and their use as a medicament
09/30/2010US20100249118 Compounds and methods for kinase modulation, and indications therefor
09/29/2010EP2233459A1 Method for producing conjugated aromatic compound
09/29/2010EP2231596A1 Histone deacetylase inhibitors
09/29/2010EP2231595A1 Phenyl acetic acid derivatives as inflammation modulators
09/29/2010EP2231594A2 Potassium ion channel modulators and uses thereof
09/29/2010EP1675824B1 Somatostatin receptor 1 and/or 4 selective agonists and antagonists
09/29/2010CN1821217B Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
09/29/2010CN101844970A Dibenzocyclooctene lignan derivatives with bioactivity
09/28/2010CA2462528C Method for producing arylsulphonic acid isocyanates
09/28/2010CA2429267C Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
09/23/2010WO2010107384A1 Aspartyl protease inhibitors
09/23/2010WO2010106364A2 Process
09/23/2010US20100240715 Apoptosis promoters
09/23/2010US20100240708 Alpha-(N-Benzenesulfonamido)Cycloalkyl Derivatives
09/22/2010EP2229942A1 2-Aryl-propionic acids and pharmaceutical compositions containing them
09/22/2010EP1786766B1 Compounds which potentiate glutamate receptor and uses thereof in medicine
09/22/2010CN101842350A New non-peptide derivatives as bradykinin Bl antagonists
09/22/2010CN101838227A Safener of benzamide herbicide
09/21/2010US7799828 selective estrogen receptor modulators such as 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene)methyl]benzoic acid, used for the treatment of osteoporosis, obesity, breast cancer, depression, vaginal dryness, rheumatoid arthritis, vasomotor symptoms and urogenital or vulvar vaginal atrophy
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2423803C Ionic liquids and their use as solvents
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/16/2010US20100234364 Ccr2 inhibitors and methods of use thereof
09/16/2010US20100234307 Preparation and use of biphenyl amino acid derivatives for the treatment of obesity
09/16/2010US20100233629 Photosensitive compostion, compound for use in the photosensitive composition and pattern forming method using the photosensitive composition
09/16/2010US20100233617 Photosensitive composition, pattern forming method using the photosensitive composition and compound for use in the photosensitive composition
09/15/2010EP2228364A1 Acylsulfonamides as inhibitors of steroid sulfatase
09/15/2010CN101830854A Substituted phenylhydrazones compounds, preparation method and application thereof
09/15/2010CN101830837A Process for the synthesis of C-2, C-3 substituted n-alkylated indoles useful as CPLA2 inhibitors
09/14/2010US7795471 Triethylamine was added dropwise to a solution of 2-methylpropane-2-sulfinyl chloride and methyl trans-4-amino-1-cyclohexane carboxylate p-toluenesulfonate in tetrahydrofuran solvent to obtain Methyl trans-4-(2-methylpropane-2-sulfonylamino)cyclohexanecarboxylate; hydrolysis; oxidation; intermediates
09/14/2010CA2422805C Retinoids for the treatment of emphysema
09/10/2010WO2010102154A2 Biaryl oxyacetic acid compounds
09/09/2010US20100228054 Method for Producing Sulfonamides
09/09/2010US20100228035 Functionalized Ionic Liquids, and Methods of Use Thereof
09/09/2010US20100228026 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
09/09/2010US20100227902 Bis-aryl sulfonamides
09/09/2010US20100227199 Blue Colour Filters with Enhanced Contrast
09/08/2010CN101823987A New DPP-IV inhibitors and preparation method and application thereof
09/07/2010US7790758 glutamate receptors agonists; especially to treat psychotic conditions, including schizophrenia and enhancement of cognition; N-{-2-[4-(6-fluoro-3-pyridinyl)phenyl]cyclopropyl}-2-propanesulfonamide; stereoselectively epoxidising a suitable styrene; coupling with boronic acid derivatives
09/07/2010US7790704 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment
09/07/2010CA2375810C Beta2-adrenoceptor agonists
09/07/2010CA2351273C Solution of n-[o-(p-pivaloyloxybenzenesulfonylamino) benzoyl] glycine monosodium salt tetra-hydrate and drug product thereof
09/02/2010WO2010097811A1 Microwave induced single step green synthesis of some novel 2-aryl aldehydes and their analogues
09/02/2010US20100222317 Azetidine Derivatives as GlyT1 Inhibitors
09/01/2010EP2222632A1 Compounds which potentiate the ampa receptor and uses thereof in medicine
09/01/2010EP2222160A2 Haloallylamine inhibitors of ssao/vap-1 and uses therefor
09/01/2010EP1379508B1 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
09/01/2010CN101821245A New compounds
09/01/2010CN101818056A Dansyl molecular probe and synthetic method and application thereof
09/01/2010CN101817767A Substituted sulphonamide compound and preparation method, medicine composition and application thereof
08/2010
08/31/2010US7786307 suchas N-(4(S)-amino-5(S)-hydroxy-2(S)-isopropyl-6-piperidin-1-ylhexyl)-2-(3-methoxypropoxy)benzamide dihydrochloride, used for the treatment of hypertension, cardiovasculr disorders, complications owing to diabetes, vision deffects, hyperaldosteronism, states of anxiety and cognitive disorders
08/31/2010US7786165 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
08/31/2010US7786161 prostaglandin receptor antagonists such as 2-(2-((4-methyl-2-(naphthalen-1-yl)pentanoyl)amino)-4-(pyrazol-1-ylmethyl) benzyl)benzoic acid, used for the prevention and/or treatment of diseases induced pain, skin disorders, allergies, urogenital disorders, Alzheimer's disease, cancer and dysmenorrhea
08/31/2010US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example
08/31/2010CA2549558C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
08/31/2010CA2374226C Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives
08/26/2010WO2010076033A9 Toluidine sulfonamides and their use
08/26/2010US20100215710 Beta-2 Adrenergic Receptor Agonists and Antagonists and Modulation of Wound Healing
08/25/2010EP2219635A2 Methods of inhibiting bacterial virulence and compounds relating thereto
08/25/2010CN101815698A Degradation accelerator for polymers and polymer article comprising it
08/25/2010CN101815512A cyclopropyl aryl amide derivatives and uses thereof
08/25/2010CN101812143A Fluorine-containing photoinitiator and application thereof
08/24/2010US7781614 treating impure organic ammonium imide composition comprising bis-trifluoromethanesulfonimide and having as an impurity a species selected from halides, sulfonates and sulfinates by liquid-liquid extraction by means of aqueous phase and 4-dimethylaminopyridine, diisopropylethylamine, dichloromethane
08/24/2010US7781613 Inhibitor of hormone sensitive lipase; non-insulin dependent diabetes; antidiabetic agents; obesity
08/24/2010US7781611 For preparing herbicidally active sulfonylureas; crop protection
08/24/2010US7781461 Neuropeptide Y receptor antagonists comprising 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide and a pharmaceutically acceptable carrier, used for the treatment of obesity and as anorexigenic agents
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
08/19/2010WO2010092180A1 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
08/19/2010WO2010092098A1 New production method
08/19/2010WO2010091543A1 Novel hydrazino-cyclobut-3-ene-1, 2-dione derivatives as cxcr2 antagonists
08/19/2010WO2010072734A3 Targeting prodrugs and compositions for the treatment of gastrointestinal diseases
08/19/2010US20100210842 Process for preparing
08/19/2010US20100210693 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
08/19/2010US20100210603 Novel sulfonamide inhibitors of aspartyl protease
08/19/2010US20100210524 Novel estrogen receptor ligands
08/19/2010CA2750793A1 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
08/19/2010CA2744949A1 New process for preparing
08/18/2010EP2217588A1 Inhibitors of histone deacetylase
08/18/2010EP2217566A1 Bis-(sulfonylamino) derivatives in therapy 066
08/18/2010EP2217565A1 Compounds which modulate the cb2 receptor
08/18/2010CN101808983A biaryl sulfonamide derivatives
08/17/2010US7776924 for gene-dependent enzyme prodrug therapy (GDEPT) and cell ablation therapy in conjunction with nitroreductase enzymes as hypoxia selective cytotoxins and as anticarcinogenic agents; 2((2-Bromoethyl)-2-{[(2-hydroxyethyl)amino]carbonyl}-4,6-dinitroanilino)ethyl methanesulfonate
08/17/2010US7776909 such as (5-acetyl-1-methyl-1H-pyrrol-2-yl)acetyl methanesulphonamide, used for the of treatment of psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), skin disorders, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and reperfusion injuries after ischemia
08/17/2010US7776902 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation
08/17/2010US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases
08/17/2010US7776558 Human G protein-coupled receptor and modulators thereof for the treatment of cell death-related disorders
08/17/2010CA2527203C Casr antagonist
08/17/2010CA2450637C Solid-phase nucleophilic fluorination
08/12/2010US20100204213 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
08/11/2010EP2216334A1 Hiv protease inhibiting sulfonamides
08/11/2010EP2215055A1 New non-peptide derivatives as bradykinin b1 antagonists
08/11/2010EP2215052A1 Desferrioxamine conjugates, derivatives and analogues
08/11/2010EP1484301B1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
08/10/2010US7772430 Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors
08/10/2010US7772425 Vitamin D receptor modulators
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 177